Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration
Movement Disorders Clinical Practice · 2024
DOI: 10.1002/mdc3.14192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2024. Verfasst von Natasha Fothergill-Misbah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Parkinson Disease, Health Services Accessibility, Caregivers, Qualitative Research. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Economic and Social Research Council.
Abstract (Originalsprache)
Background
The accessibility of Parkinson's disease medicines is limited across sub‐Saharan Africa, which can have negative health, social and financial consequences for people with Parkinson's disease and their families. However, there is a stark gap in the literature regarding the impact of poor access to medicines on individuals.
Objectives
The study objective was to understand the accessibility of Parkinson's disease medicines in Kenya from the perspective of people with Parkinson's disease, their caregivers and neurologists.
Methods
In‐depth qualitative interviews were conducted with 55 people with Parkinson's disease, 23 caregivers and 8 neurologists to understand their experience regarding challenges with accessing Parkinson's disease medicines and the health, social and financial impact of poor availability and affordability.
Results
Medicines for Parkinson's disease were deemed to be largely unavailable and unaffordable across Kenya. People with Parkinson's disease, caregivers and neurologists expressed the financial burden caused by long‐term treatment in the absence of health insurance coverage. Further, barriers accessing medicines negatively impacted symptom control, social relations, and quality of life.
Conclusions
Access to Parkinson's disease medicines in Kenya is limited, with severe implications for symptom management and quality of life. People with Parkinson's disease should be able to access and afford the medicines they need to manage their condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
- Aga Khan University Hospital, Nairobi, Kenya.
- Department of Medicine, University of Nairobi, Nairobi, Kenya.
- Northumbria Healthcare NHS Foundation Trust, Newcastle upon Tyne, UK.
ORCID-Profile: Natasha Fothergill-Misbah
Förderung
- Economic and Social Research Council
Zitieren
APA
Fothergill-Misbah, N., Hooker, J., Kwasa, J., & Walker, R. (2024). Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14192
Vancouver
Fothergill-Misbah N, Hooker J, Kwasa J, Walker R. Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration. Movement Disorders Clinical Practice. 2024. doi:10.1002/mdc3.14192
BibTeX
@article{FothergillMisbah2024,
author = {Fothergill-Misbah, Natasha and Hooker, Juzar and Kwasa, Judith and Walker, Richard},
title = {Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration},
journal = {Movement Disorders Clinical Practice},
year = {2024},
doi = {10.1002/mdc3.14192}
}
EUVIMED